Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Etiologics Ltd.
In its late-stage licensing deal with GW Pharmaceuticals for Sativex, Bayer accepted UK-only rights, and will share the product's value equally with GW. This unusual agreement largely reflects the particular nature of the product. But it also shows that, at least in some situations, biotechs can still partner out their jewels without giving away too much value.
Summarizing the month in European dealmaking.
- Drug Discovery Tools